Belite Bio Inc
NASDAQ:BLTE
Cash Flow Statement
Cash Flow Statement
Belite Bio Inc
| Dec-2021 | ||
|---|---|---|
| Operating Cash Flow | ||
| Net Income |
(10)
|
|
| Depreciation & Amortization |
0
|
|
| Stock-Based Compensation |
2
|
|
| Other Non-Cash Items |
2
|
|
| Cash Interest Paid |
0
|
|
| Change in Working Capital |
1
|
|
| Cash from Operating Activities |
(7)
N/A
|
|
| Investing Cash Flow | ||
| Capital Expenditures |
(0)
|
|
| Other Items |
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
|
| Financing Cash Flow | ||
| Net Issuance of Common Stock |
0
|
|
| Net Issuance of Debt |
0
|
|
| Other |
(1)
|
|
| Cash from Financing Activities |
(1)
N/A
|
|
| Change in Cash | ||
| Effect of Foreign Exchange Rates |
(0)
|
|
| Net Change in Cash |
(8)
N/A
|
|
| Free Cash Flow | ||
| Free Cash Flow |
(8)
N/A
|
|